Medical College of Wisconsin

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Medical College of Wisconsin sits in the top decile of US sponsors by registered trial count (#79 of 15,742 sponsors by registered trial count).

447 total trials 95 currently recruiting 236 completed early-phase tilt top decile by trial count

Medical College of Wisconsin: 447 sponsored US clinical trials, 95 recruiting.

Medical College of Wisconsin sponsors 447 registered US clinical trials on ClinicalTrials.gov, 95 of them currently recruiting, and 236 completed. 28 of these trials are in Phase 3-4 (later-stage) and 129 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 10 trials.

Top-decile sponsor footprint

Medical College of Wisconsin ranks in the top decile of sponsors by registered trial count (#79 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 46/100

236 of 286 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

447 total, page 5 of 9

COMPLETED NA

Ketamine for Pain Control After Severe Traumatic Injury

NCT04274361
COMPLETED NA

Analyzing Preoperative Stereotactic Radiosurgery With Gamma Knife Icon for Brain Metastases

NCT04545814
COMPLETED

PPCM Observational Study (Peripartum Cardiomyopathy)

NCT04234659
COMPLETED

Topical Antisepsis in Head and Neck Cancer Surgery

NCT04721626
COMPLETED NA

Implementation of an Evidence Based Parentally Administered Intervention for Preterm Infants

NCT04555590
TERMINATED NA

Effect of Sleep Quality on Hematopoietic Cell Transplant Patient Outcomes

NCT04271930
TERMINATED Phase 1

CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL

NCT04049383
TERMINATED Phase 4

Cardiac Uptake of 18F Florbetapir in Patients Undergoing Chemotherapy

NCT03333551
COMPLETED NA

Acute Probiotic Supplementation and Endothelial Function

NCT04364074
TERMINATED NA

Nudges to Improve Health Behaviors That Limit COVID-19 Spread

NCT04379375
COMPLETED

Self-sampling for the Study of COVID-19

NCT04447495
COMPLETED Phase 2

Efficacy and Safety of Convalescent Plasma in Treating COVID-19 Hospitalized Patients

NCT04354831
COMPLETED Phase 2

Tildrakizumab for Prevention of Acute Graft-Versus-Host Disease

NCT04112810
COMPLETED NA

HDtDCS in Logopenic Variant PPA: Effects on Language and Neural Mechanisms

NCT03805659
COMPLETED NA

Preemie Prep For Parents (P3): Home Antenatal Prematurity Education

NCT04093492
COMPLETED NA

Singing and Cardiovascular Health in Older Adults

NCT04121741
COMPLETED NA

The Prevent Anal Cancer Palpation Study

NCT04090060
TERMINATED Phase 1

Pevonedistat, Azacitidine (or Decitabine), and Venetoclax for the Treatment of Patients With Acute Myelogenous Leukemia

NCT04172844
COMPLETED NA

The Prevent Anal Cancer Self-Swab Study

NCT03489707
COMPLETED NA

Order Effects of Prematurity Outcome Data

NCT04269616
COMPLETED NA

Effects of Transcranial Direct Current Stimulation (tDCS) on Language

NCT04166513
TERMINATED NA

Early Cycle Ergometry for Critically-Ill Liver Failure Patients in a Transplant Intensive Care Unit

NCT04160039
COMPLETED NA

Avanzando Juntas: Adapting an Evidence Based Weight Loss Program for Hispanic Breast Cancer Survivors

NCT04321135
COMPLETED NA

Evaluation of Hemodynamic Parameters Following Transjugular Intrahepatic Portosystemic Shunt (TIPS)

NCT04050683
COMPLETED NA

Health Literacy - Neurocognitive Screening in Pediatric SCD

NCT04917783
COMPLETED Early Phase 1

Transgender Estradiol

NCT04036500
COMPLETED

STeP IT UP CF: STimulating ImProved Health And Well-being In CysTic Fibrosis

NCT04018495
TERMINATED Phase 4

Patients Receiving Induction With Liposomal Daunorubicin and Cytarabine (CPX-351) for Acute Myeloid Leukemia

NCT03988205
TERMINATED NA

Virtual Reality Education Program to Reduce Anxiety During Radiation Therapy

NCT04029961
COMPLETED Phase 2

A Trial of Vitamin B12 in Septic Shock

NCT03783091
COMPLETED

A Pilot Study of Reducing Test-Anxiety in a Cohort of Underrepresented in Medicine MCAT Students Using Near-Peer Coaching

NCT05224427
COMPLETED Phase 1

Vancomycin for the Treatment of NAAT(+)/Toxin(-) C. Difficile

NCT03827447
COMPLETED NA

Ischemic Conditioning Chronic Stroke Study

NCT04039399
COMPLETED Phase 3

TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)

NCT03959241
COMPLETED NA

Active Injury Management (AIM) After Pediatric Concussion

NCT03869970
COMPLETED NA

Oligosaccharide for Cdiff(+) Heme-onc Patients

NCT03778606
COMPLETED Phase 1

Pracinostat and Gemtuzumab Ozogamicin (PraGO) in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT03848754
COMPLETED NA

Impact of Pre-Sedation Virtual Reality Game on Post-Discharge Negative Behaviors in the Pediatric Emergency Department

NCT03980067
COMPLETED

The Influence of Non-Caloric Artificial Sweeteners on Youth With Type 1 Diabetes

NCT03889522
TERMINATED NA

Effectiveness of Electrical Neurostimulation in Cyclic Vomiting Syndrome.

NCT04721171
COMPLETED Phase 2

t-PA Prophylaxis to Prevent Catheter-associated Thrombosis and Infection

NCT03672006
TERMINATED NA

Customized Orthosis for Children With Clubfoot

NCT03853811
COMPLETED Phase 2

Network-Level Mechanisms for Preclinical Alzheimer's Disease Development

NCT03461861
COMPLETED NA

Avoiding Health Disparities When Collecting Patient Contextual Data for Clinical Care and Pragmatic Research

NCT03766841
COMPLETED NA

Prehabilitation of Frail Surgical Cancer Patients Using Remote Ischemic Preconditioning

NCT03853473
COMPLETED NA

Does Improving Vagal Tone Increase Mitochondrial Bioenergetics

NCT03931330
TERMINATED Phase 2

Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm Infants

NCT02620761
TERMINATED NA

Clinical Translational Science Institute (CTSI) Brain HQ Modules vs. Active Controls for Elderly Survivors of ICU

NCT04081090
COMPLETED Phase 2

PROACTIVE: Preventing Acute/Chronic GVHD With TocIlizumab Combined With GVHD Prophylaxis Post allogEneic Transplant

NCT03699631
COMPLETED NA

AB-Intra- and Post-Operative Measures of Auditory Function

NCT03685461
← Previous Page 5 of 9 Next →

Phase Distribution

PhaseTrial count
Phase 1 49
Phase 2 80
Phase 3 13
Phase 4 15

Therapeutic Areas

Stroke 10
Breast Cancer 9
Burkitt Lymphoma 5
Aphasia 5
Prostate Cancer 5
Type 1 Diabetes Mellitus 4
Multiple Myeloma 4
Glioblastoma 4
Cardiovascular Diseases 4
Type 1 Diabetes 4

What is open in the Medical College of Wisconsin pipeline

95 recruiting of 447 indexed (21% open); 236 completed (53%).

Phase mix: 28 late (III/IV) vs 129 early (I/II) (early-phase heavy).

Top condition: Stroke (10 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Medical College of Wisconsin: open-pipeline peers nationwide

Peers matched on 447 registered trials and 21% open enrollment, not the therapeutic-area sidebar.

Medical College of Wisconsin sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600 5%10%15%20%25% Total trials Recruiting share Medical College of WisconsinAlliance for Clinical Trials in OncologyUniversity of VirginiaBoston Children's HospitalChildren's Hospital of PhiladelphiaColorado State UniversityUniversity of LouisvilleOhio State UniversityNova Southeastern University
Medical College of Wisconsin sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Medical College of Wisconsin sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 447 trials (± recruiting share)

Sponsors near 21% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Medical College of Wisconsin page

447 registered trials is a research-attention snapshot, not an endorsement of Medical College of Wisconsin or any single study.

  • 95 of Medical College of Wisconsin's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Stroke is the condition Medical College of Wisconsin studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Medical College of Wisconsin pipeline card: 447 registered trials from official public datasets.Report a data error.